We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Expression Profiles Define Microbial Infection

By LabMedica International staff writers
Posted on 08 Aug 2013
Print article
Image: Microarray assay result (Photo courtesy of Ashley Vance).
Image: Microarray assay result (Photo courtesy of Ashley Vance).
A molecular test distinguishes between viral and bacterial infections in children with fever by profiling the activity of genes in a blood sample.

In febrile children, it is difficult to know whether the child has a viral infection that will resolve on its own or a potentially serious bacterial infection that requires antibiotics.

Scientists at Washington University School of Medicine (St. Louis, MO, USA) can distinguish between viral and bacterial infections in children with fever by profiling the activity of genes in white blood cells. They studied 30 children ages two months to three years who had fevers above 38 °C, but no obvious signs of illness, like a cough or diarrhea. Twenty-two of the children were known to have viral infections based on previous extensive genomic testing that is not yet practical to use in a clinic setting, and eight others children had bacterial infections.

The investigators used a test called a gene expression microarray that could identify patterns of gene activity in white blood cells and could discriminate children with viral infections from those with bacterial infections. In addition to whole-blood and nasopharyngeal samples for virus specific polymerase chain reaction (PCR) and high-throughput sequencing, a blood sample was collected in a Tempus Blood Ribonucleic Acid (RNA) Tube (Applied Biosystems, Foster City, CA, USA; www.appliedbiosystems.com) and stored at -80 °C for subsequent gene expression analysis.


The microarray technology enabled the team to easily distinguish bacterial infections from viral infections based on distinctive patterns of gene expression. As a comparison, the scientists performed the microarray analysis on blood samples from 35 children without fever, also ages two months to three years, who were having outpatient surgery. Earlier genomic testing showed that eight of those children had viruses, even though they did not cause any symptoms.

Gregory A. Storch, MD, a professor of pediatrics and senior author of the study said, “In the kids with a virus and a fever, many genes were very active, compared with kids who had viruses and no fever, whose genes were quiet. The microarray basically tells us how a patient is reading the infection. The very active genes tell us that an infection is making a patient sick, while quiet genes tell us either there's no infection or maybe a bacterium or virus is there, but it's not causing fever or illness.” The potential benefit of using tests that measures the response of genes to get more conclusive answers to illness. This would help to ensure that antibiotics are targeted to those children who really need them. The study was published on July 15. 2013, in the Proceedings of the National Academy of Science of the United States of America (PNAS).

Related Links:

Washington University School of Medicine

Applied Biosystems


Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA
Unit-Dose Packaging solution
HLX
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.